• There is a consensus that synthetic mesh must be avoided in infected operations, and the alternatives to using synthetic mesh, such as component separation techniques and biologic mesh, present disappointing results with expressive wound infection and hernia recurrence rates. (bioportfolio.com)
  • Recently COX-2 has been reported to frequently overexpress in colorectal neoplasms and to play a role in colorectal tumorigenesis and tumour progression. (nih.gov)
  • Predicting biochemical recurrence and prostate cancer specific mortality after radical prostatectomy: comparison of six prediction models in a cohort of screen and clinically detected prostate cancer patients. (urotoday.com)
  • To perform a comparison and external validation of three models predicting biochemical recurrence (BCR) and three models predicting prostate cancer specific mortality (PCSM) in a screening setting, i. (urotoday.com)
  • The insertion of a pericardial catheter for prolonged drainage or pericardial sclerosis provides more definitive freedom from recurrence, without a significant increase in periprocedural mortality or morbidity. (acc.org)
  • The aim of this study was to characterize patterns of local progression following resection for pancreatic intraductal papillary mucinous neoplasms (IPMN) using targeted next-generation sequencing (NGS). (ovid.com)
  • Given these exciting advances, we are currently studying the effectiveness of DNA-based stool tests for the detection of pancreatic cancer and its precursor, intraductal papillary mucinous neoplasms (IPMN) in collaboration with Dr. David Ahlquist's group at the Mayo Clinic. (columbiasurgery.org)
  • or =1 cm, lobectomy resulted in higher risk of recurrence and death (P = 0.04, P = 0.009). (nih.gov)
  • 1 ] Although some thymoma histologic types are more likely to be invasive and clinically aggressive, treatment outcome and the likelihood of recurrence appear to correlate more closely with the invasive/metastasizing properties of the tumor cells. (healthlinkbc.ca)
  • Only two clinical practice guidelines suggest its potential use in thyroid cancer recurrence and no coverage policies were found mentioning this technology. (york.ac.uk)